Grand Sponsor

Cosmos Health Inc.

Cosmos Health Inc. (NASDAQ: COSM), ("Cosmos" or the "Company"), is a diversified, vertically integrated global healthcare group based in Thessaloniki. Incorporated in 2009, the Company has solidified its position as a key player in the healthcare industry, offering a wide array of innovative products and services. Specializing in nutraceuticals, pharmaceuticals, and healthcare distribution, Cosmos is dedicated to improving accessibility to essential healthcare products and delivering exceptional healthcare solutions. The Company also places significant emphasis on R&D and leveraging digital advancements, while investing in multiple innovative areas, including artificial intelligence, to elevate the quality and diversity of its assets.

Cosmos owns a diverse portfolio of proprietary brands. Sky Premium Life® and Mediterranation®, the Company’s nutraceutical brands, are carefully formulated with high-quality raw materials to promote wellness. They are experiencing significant market success and are sold in an increasing number of countries through pharmacies, retail chains such as Holland & Barrett, one of the world's largest health and wellbeing retailers, and online platforms such as Amazon in the US, Canada, UK, Europe, and Singapore. Cosmos is also expanding its portfolio into new categories via bio-bebe, an organic infant care and nutrition brand, and related baby-related products such as detergents, and C-Sept, a global antiseptic and disinfectant brand, which is expanding with the launch of the new C-Scrub Wash 4% CHG Biocide aimed for hospitals.

In the pharmaceutical sector, Cosmos provides a wide range of branded generics and OTC medications, and has manufacturing capabilities following the strategic acquisition of Cana Laboratories ("Cana"). Licensed under European Good Manufacturing Practices (GMP) and certified by EMA, Cana allows for synergies and vertical integration, enhancing operational efficiency, and has been trusted by the world's leading pharmaceutical companies. It can produce its own food supplements, cosmetics, biocides, medical devices, and pharmaceutical products, including medicines, as well as engage in contract manufacturing for third-party multinationals as clients.

In the healthcare distribution sector, Cosmos has a strong presence, serving retail pharmacies and wholesale distributors. Its facilities leverage robotic technologies to automate procurement, inventory management, and order execution, enhancing service quality and ensuring efficient and timely deliveries.

R&D is a key priority for Cosmos. The Company is committed to developing novel patented nutraceuticals, specialized root extracts, and proprietary complex generics, and is also focused on innovative projects targeting major health disorders such as obesity and diabetes. One of its most ambitious projects, centered around leveraging the microbiome for obesity management, is scheduled to enter clinical trials shortly.

Cosmos has a global vision and has established regional hubs through its subsidiaries to support its growth strategies. In Greece, CosmoFarm, Sky Pharm, and Cana operate facilities catering to the European market. In England, Decahedron assists in the Company's operations in the UK. Cosmos is actively seeking additional facilities to accelerate its entry into the US market. To drive growth and expand its capabilities, Cosmos has made several important acquisitions. The acquisition of Texas-based ZipDoctor marked the Company's entry into the US telehealth space. Cosmos is further investing in new technologies through the pending acquisition of Cloudscreen, a cutting-edge AI-powered drug repurposing platform. Additionally, the acquisition of assets from I. Bikas GP has further strengthened its position in the distribution industry, granting it access to a larger network of pharmacies.

With a dedicated acquisition strategy, strong focus on R&D, robust balance sheet, and commitment to organic growth, Cosmos has positioned itself as a prominent player in the global healthcare industry, driving positive change and delivering innovative solutions.